<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04769934</url>
  </required_header>
  <id_info>
    <org_study_id>2018-00666</org_study_id>
    <nct_id>NCT04769934</nct_id>
  </id_info>
  <brief_title>Impact of Implant Insertion Torque on Peri-implant Bone Level.</brief_title>
  <official_title>Impact of Implant Insertion Torque on Peri-implant Bone Level.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Geneva, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Geneva, Switzerland</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study with one single arm. The purpose of this study was to evaluate the impact&#xD;
      of the insertion torque and of the implant stability on the marginal bone level changes for&#xD;
      dental implants placed into healed ridges.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcome would be to evaluate the peri-implant bone level changes (marginal bone&#xD;
      level) around the implant platform.&#xD;
&#xD;
      The secondary outcomes would be:&#xD;
&#xD;
        -  To evaluate the Implant Stability Quotient (ISQ) changes according to the measurements&#xD;
           performed with the instrument Penguin RFA&#xD;
&#xD;
        -  To evaluate the implant and prosthetic failure rate as well as the implant and&#xD;
           prosthetic complication rates&#xD;
&#xD;
        -  The patient satisfaction related to the implant treatment&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>radiographic marginal bone level changes around the implant platform</measure>
    <time_frame>3 years</time_frame>
    <description>the changes (in mm) of the marginal bone level around the implant platform</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant Stability Quotient (ISQ) changes</measure>
    <time_frame>3 years</time_frame>
    <description>the measurements will be performed with the instrument Penguin RFA</description>
  </secondary_outcome>
  <other_outcome>
    <measure>implant failure rate</measure>
    <time_frame>3 years</time_frame>
    <description>% of implant failure</description>
  </other_outcome>
  <other_outcome>
    <measure>patient satisfaction related to the implant treatment</measure>
    <time_frame>3 years</time_frame>
    <description>degree of satisfaction on factors such as function, comfort and esthetics through questionnaires</description>
  </other_outcome>
  <other_outcome>
    <measure>prosthetic failure rate</measure>
    <time_frame>3 years</time_frame>
    <description>% of prosthetic failure</description>
  </other_outcome>
  <other_outcome>
    <measure>implant complications rate</measure>
    <time_frame>3 years</time_frame>
    <description>% of implant complications</description>
  </other_outcome>
  <other_outcome>
    <measure>prosthetic complications rate</measure>
    <time_frame>3 years</time_frame>
    <description>% of prosthetic complications</description>
  </other_outcome>
  <enrollment type="Anticipated">93</enrollment>
  <condition>Implant Complication</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Penguin RFA</intervention_name>
    <description>to evaluate the peri-implant bone level changes (marginal bone level) around the implant platform.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        partially edentulous patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All partially edentulous patients requiring simple Implant placement,&#xD;
&#xD;
          -  being at least 18-year-old and able to sign an informed consent,&#xD;
&#xD;
          -  The patients that will be enrolled must have a bone quantity that allows the placement&#xD;
             of regular implants according to the radiographic evaluations (pre-operative&#xD;
             radiographic examination).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heavy smokers (more than 10 cigarettes/day).&#xD;
&#xD;
          -  Immunosuppressed or immunocompromised patients&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Active periodontal disease&#xD;
&#xD;
          -  Patients with a full mouth marginal bleeding score higher than 20%&#xD;
&#xD;
          -  Addiction to alcohol or drugs&#xD;
&#xD;
          -  Psychiatric problems&#xD;
&#xD;
          -  Severe caries, periapical lesions, acute infection (abscess)&#xD;
&#xD;
          -  Immediate post-extractive implants (at least 2 months after extraction have to elapse)&#xD;
&#xD;
          -  Patients unable to commit to 3-year follow-up.&#xD;
&#xD;
          -  Patients treated or under treatment with intravenous amino- bisphosphonates.&#xD;
&#xD;
          -  Patients participating to other studies, if the present protocol could not be fully&#xD;
             adhered to.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irena Sailer, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irena Sailer, Prof. Dr.</last_name>
    <phone>+41 22 3794050</phone>
    <email>irena.sailer@unige.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Geneva</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irena Sailer, Prof. Dr.</last_name>
      <phone>+41 22 3794050</phone>
      <email>irena.sailer@unige.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>February 21, 2021</last_update_submitted>
  <last_update_submitted_qc>February 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Geneva, Switzerland</investigator_affiliation>
    <investigator_full_name>Irena Sailer</investigator_full_name>
    <investigator_title>Prof. Dr. Irena Sailer, Head of the Division</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

